YOKNEAM, Israel, September 19, 2017 /PRNewswire/ -- - The post marketing registry will assess the real-life safety and performance of the TIGERTRIEVER revascularization device Today, Rapid Medical, a company focused on the development of neurovascular interventional devices, announced that the first patient was enrolled to the TIGERTRIEVR registry at the Cantonal Hospital of Lucerne, Switzerland.The TIGERTRIEVER is a one-of-a-kind, fully-visible, controllable stentriever that is adjusted to perfectly fit the dimensions of a blocked blood vessel causing acute ischemic stroke. The TIGERTRIEVER registry is a European multi-center registry that will enroll patients from leading centers in France
Thank you for a succesful congress @ ESMINT, looking forward to meet you all again @ WFITN 2017, Budapest
Another successful Mechanical Thrombectomy treatment with Tigertriever. Images in the courtesy of Dr. Markus Holtmannspötter, Rigshospitalet, Copenhagen.
